More on severe cutaneous reaction with radiotherapy and cetuximab.
Bonner
James A
JA
Ang
Kian
K
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D000068818:Cetuximab; D003131:Combined Modality Therapy / Q000009:adverse effects; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000378:metabolism; D011855:Radiodermatitis / Q000209:etiology*; D020266:Radiotherapy, Conformal / Q000009:adverse effects; D051437:Renal Insufficiency / Q000276:immunology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab